Redirecting to https://www.manilatimes.net/2025/10/25/tmt-newswire/globenewswire/blossomhill-therapeutics-presents-preliminary-findings-from-phase-12-solara-trial-of-bh-30643-in-egfr-mutant-nsclc-at-the-aacr-nci-eortc-international-conference-on-molecular-targets-and-cancer-therapeutics/2208168